Salas-Alanis J C, Mellerio J E, Amaya-Guerra M, Ashton G H, Eady R A, McGrath J A
Servicios Médicos de la Universidad Autonóma de Nuevo León, Monterrey, Mexico.
Br J Dermatol. 1998 May;138(5):852-8. doi: 10.1046/j.1365-2133.1998.02225.x.
Dystrophic epidermolysis bullosa (DEB) is caused by mutations in the type VII collagen gene (COL7A1). In this study, we assessed the molecular basis of recessive DEB in five affected individuals from two Mexican families. Both fathers of the affected children were first cousins. Genomic DNA was extracted from peripheral blood samples and assessed for COL7A1 mutations by polymerase chain reaction (PCR) amplification, heteroduplex analysis and direct automated sequencing of PCR products displaying heteroduplex bandshifts. In one family, we identified a homozygous 1 bp insertion of a G nucleotide in exon 19 of COL7A1, designated 2470insG, in three affected sisters. This mutation causes a frameshift and a premature termination codon on both alleles 178 bp downstream from the insertion; both parents were shown to be heterozygous carriers of this mutation. In the second family, the father of the other two affected children was also found to be a heterozygous carrier of this frameshift mutation. In addition, his unrelated partner was shown to be a heterozygous carrier of a different COL7A1 frameshift mutation, an insertion of a T nucleotide in exon 32, designated 3948insT. This mutation also results in a premature termination codon, 126 bp downstream from the insertion. Both affected children were compound heterozygotes for the 2470insG/3948insT mutations in COL7A1. Overall, these molecular findings offer a genetic explanation for the skin fragility in these related Mexican patients with recessive DEB. Immediate benefits from elucidation of the mutations include assessment of carrier status in other members of the family and the feasibility of DNA-based prenatal testing in subsequent pregnancies.
营养不良性大疱性表皮松解症(DEB)由VII型胶原蛋白基因(COL7A1)突变引起。在本研究中,我们评估了来自两个墨西哥家庭的五名患病个体中隐性DEB的分子基础。患病儿童的父亲均为近亲。从外周血样本中提取基因组DNA,通过聚合酶链反应(PCR)扩增、异源双链分析以及对显示异源双链带移的PCR产物进行直接自动测序来评估COL7A1突变。在一个家庭中,我们在三名患病姐妹的COL7A1基因第19外显子中鉴定出一个纯合的1 bp G核苷酸插入,命名为2470insG。该突变导致移码,并在插入位点下游178 bp处的两个等位基因上产生提前终止密码子;父母双方均为该突变的杂合携带者。在第二个家庭中,另外两名患病儿童的父亲也被发现是这种移码突变的杂合携带者。此外,他的无关配偶被证明是另一种不同的COL7A1移码突变的杂合携带者,即第32外显子中插入一个T核苷酸,命名为3948insT。该突变也导致提前终止密码子,位于插入位点下游126 bp处。两名患病儿童均为COL7A1基因2470insG/3948insT突变的复合杂合子。总体而言,这些分子研究结果为这些患有隐性DEB的墨西哥相关患者的皮肤脆弱性提供了遗传学解释。阐明这些突变的直接益处包括评估家族中其他成员的携带者状态以及后续妊娠中基于DNA的产前检测的可行性。